Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 3,952 shares at $5.54 ($22K) on 2021-05-04, disclosed to the SEC on 2021-05-04.
Open-market sale of $22k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.54 | 1,769 | $10K | 44.8% |
| 2 | $5.54 | 2,183 | $12K | 55.2% |
| Total | $5.54 avg | 3,952 | $22K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |